AAUM (Average Assets Under Management) of ₹2,259.32 Cr for Apr-Jun 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 70.2% | 71.2% | ▲ +1.0% |
| Healthcare Services | 26.5% | 27.9% | ▲ +1.4% |
| Healthcare Equipment & Supplies | 0.6% | 0.5% | ● -0.1% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 71.2% | 72.1% | ▲ +0.9% |
| Healthcare Services | 27.9% | 24.2% | ▼ -3.7% |
| Healthcare Equipment & Supplies | 0.5% | 2.2% | ▲ +1.7% |
Comparing Jul 2026 → Aug 2026
| # | Stock | Sector | Weight (Aug 2026) |
|---|---|---|---|
| 1 | Molbio Diagnostics Ltd. ₹58.44 Cr |
Healthcare Equipment & Supplies | 1.77% |
| 2 | Symbiotec Pharmalab Limited ₹40.00 Cr |
Pharmaceuticals & Biotechnology | 1.21% |
| # | Stock | Sector | Jul 2026 | Aug 2026 | Change |
|---|---|---|---|---|---|
| 1 | Torrent Pharmaceuticals Limited ₹135.00 Cr |
Pharmaceuticals & Biotechnology | 2.28% | 4.08% | +1.80% |
| 2 | Rubicon Research Limited ₹93.29 Cr |
Pharmaceuticals & Biotechnology | 1.61% | 2.82% | +1.21% |
| 3 | Shilpa Medicare Ltd ₹102.60 Cr |
Pharmaceuticals & Biotechnology | 2.25% | 3.10% | +0.85% |
| 4 | Divi's Laboratories Limited ₹315.90 Cr |
Pharmaceuticals & Biotechnology | 9.14% | 9.54% | +0.40% |
| 5 | Neuland Laboratories Limited ₹122.33 Cr |
Pharmaceuticals & Biotechnology | 3.40% | 3.70% | +0.30% |
| 6 | Gland Pharma Limited ₹36.13 Cr |
Pharmaceuticals & Biotechnology | 1.07% | 1.09% | +0.02% |
| 7 | IPCA Laboratories Limited ₹106.99 Cr |
Pharmaceuticals & Biotechnology | 3.22% | 3.23% | +0.01% |
| 8 | Vijaya Diagnostic Centre Limited ₹74.11 Cr |
Healthcare Services | 2.23% | 2.24% | +0.01% |
| # | Stock | Sector | Jul 2026 | Aug 2026 | Change |
|---|---|---|---|---|---|
| 1 | Aster DM Healthcare Limited ₹127.09 Cr |
Healthcare Services | 4.70% | 3.84% | -0.86% |
| 2 | Max Healthcare Institute Limited ₹134.30 Cr |
Healthcare Services | 4.82% | 4.06% | -0.76% |
| 3 | Sun Pharmaceutical Industries Limited ₹296.04 Cr |
Pharmaceuticals & Biotechnology | 9.66% | 8.94% | -0.72% |
| 4 | Cipla Limited ₹130.36 Cr |
Pharmaceuticals & Biotechnology | 4.64% | 3.94% | -0.70% |
| 5 | Lupin Limited ₹133.82 Cr |
Pharmaceuticals & Biotechnology | 4.67% | 4.04% | -0.63% |
| 6 | Alkem Laboratories Limited ₹101.17 Cr |
Pharmaceuticals & Biotechnology | 3.67% | 3.06% | -0.61% |
| 7 | Jupiter Life Line Hospitals Limited ₹64.29 Cr |
Healthcare Services | 2.45% | 1.94% | -0.51% |
| 8 | Krishna Institute Of Medical Sciences Limited ₹74.39 Cr |
Healthcare Services | 2.70% | 2.25% | -0.45% |
| 9 | Fortis Healthcare Limited ₹78.62 Cr |
Healthcare Services | 2.79% | 2.37% | -0.42% |
| 10 | Acutaas Chemicals Ltd ₹107.15 Cr |
Pharmaceuticals & Biotechnology | 3.58% | 3.24% | -0.34% |
39 stocks — Aug 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹315.90 Cr |
Pharmaceuticals & Biotechnology |
9.54%
|
|
| 2 |
₹296.04 Cr |
Pharmaceuticals & Biotechnology |
8.94%
|
|
| 3 |
₹135.00 Cr |
Pharmaceuticals & Biotechnology |
4.08%
|
|
| 4 |
₹134.30 Cr |
Healthcare Services |
4.06%
|
|
| 5 |
₹133.82 Cr |
Pharmaceuticals & Biotechnology |
4.04%
|
|
| 6 |
₹130.36 Cr |
Pharmaceuticals & Biotechnology |
3.94%
|
|
| 7 |
₹127.09 Cr |
Healthcare Services |
3.84%
|
|
| 8 |
₹122.33 Cr |
Pharmaceuticals & Biotechnology |
3.70%
|
|
| 9 |
₹115.35 Cr |
Pharmaceuticals & Biotechnology |
3.48%
|
|
| 10 |
₹107.15 Cr |
Pharmaceuticals & Biotechnology |
3.24%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.